2007
DOI: 10.1016/j.jpba.2006.06.046
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a new impurity in lisinopril

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…A wide variety of separation and detection techniques have been applied to the analysis of lisinopril, such as gas chromatography coupled with mass spectrometry (GC/MS) [3][4] , high performance liquid chromatography (HPLC) [5][6] , and high performance liquid chromatography coupled with mass spectrometry (HPLC/MS) [7][8] . The degradation profile of a drug substance is critical to its safety assessment and formulation process in addition to dosage form administration.…”
Section: Lisinopril2s)-1-[(2s)-6-amino-2-{[(1s)-1-carboxy-3-phenylprmentioning
confidence: 99%
“…A wide variety of separation and detection techniques have been applied to the analysis of lisinopril, such as gas chromatography coupled with mass spectrometry (GC/MS) [3][4] , high performance liquid chromatography (HPLC) [5][6] , and high performance liquid chromatography coupled with mass spectrometry (HPLC/MS) [7][8] . The degradation profile of a drug substance is critical to its safety assessment and formulation process in addition to dosage form administration.…”
Section: Lisinopril2s)-1-[(2s)-6-amino-2-{[(1s)-1-carboxy-3-phenylprmentioning
confidence: 99%
“…Some examples found in recent literature point out to special precautions required during complex syntheses. The structural analysis (MS, IR, and 200 MHz 1 H and 13 C NMR) of an impurity isolated from lisinopril revealed it to be a result from incomplete protection of the starting material [136]. An impurity was isolated from benazepril and subjected to spectroscopic analysis using LC-MS/MS, MS, NMR ( 1 H and 13 C) and FT-IR.…”
Section: Impurities In Synthetic Active Pharmaceutical Ingredientsmentioning
confidence: 99%
“…Lisinopril members angiotensin converting enzyme (ACE) inhibitors and belongs to a group of cardiovascular pharmaceuticals group. They are generally used for the treatment of high blood pressure, angina, arrhythmias, hyperthyroidism, myocardial infarction [14][15][16][17][18]. Excipients can be classified as the basis of their origin, mechanisms and they use in dosage form-functions [19].…”
Section: Introductionmentioning
confidence: 99%